Novel fluorinated polycationic delivery of anti-VEGF siRNA for tumor therapy

• Published in: NPG Asia materials Vol. 12; no. 1
• Main Authors: Yuan, Zihan, Guo, Xiaoshuang, Wei, Minyan, Xu, Yang, Fang, Zhiwei, Feng, Yun, Yuan, Wei-En
• Format: Journal Article
• Language: English
• Published: London Nature Publishing Group UK 2020; Nature Publishing Group
• Subjects: 631/61/54/152; 639/301/54/152; Antiangiogenics; Biocompatibility; Biomaterials; Cancer; Cell membranes; Chemistry and Materials Science; Energy Systems; Experiments; Fluorine; Fluoropolymers; Gene expression; Genes; Health services; In vivo methods and tests; Lipids; Low molecular weights; Materials Science; Membrane structures; Nucleic acids; Optical and Electronic Materials; Polyelectrolytes; Polyethyleneimine; Polymer coatings; Polymers; Polytetrafluoroethylene; Ribonucleic acid; RNA; Silence; Structural Materials; Surface and Interface Science; Thin Films; Toxicity; Tumors
• ISSN: 1884-4049; 1884-4057
• DOI: 10.1038/s41427-020-0216-9

Small-interfering RNA (siRNA) can specifically silence disease gene expression, bringing hope for the effective treatment of gene-related diseases. However, its use in vivo is limited due to the lack of efficient carriers. Therefore, it is necessary to construct carriers with high efficiency, low toxicity and serum stability. As a promising polycation carrier, polyethylenimine (PEI) can be further modified with a fluorine-containing alkyl chain that brings hydrophobic and oleophobic characteristics to its surface. In this study, low molecular weight PEI 1.8 kDa was selected and fluorinated through an anhydride reaction, and the product was named PEIF. In vitro experiments have shown that PEIF/siRNA polyplexes have suitable and stable particle size and potential, compress nucleic acids at a very low w / w ratio, and have the ability to effectively silence specific genes with low cytotoxicity. Compared with the polyplexes prepared using PEI 25 kDa, the PEIF/siRNA polyplexes were more stable in serum, showed a better antiangiogenic ability in in vivo experiments, and had a better tumor inhibition effect. The above results indicate that fluoropolymers based on the fluorine effect have great potential as gene delivery carriers for tumor therapy. Cancer treatment: Silencing critical genes without going viral A polymer that helps nucleic acids sneak into cancer cells so they can suppress expression of critical genes shows beneficial effects in animal testing. Efforts to genetically re-program tumors using small RNA molecules have often used viruses as carriers capable of penetrating cell membranes. Wei-En Yuan from China’s Shanghai Jiao Tong University and colleagues have now developed a less hazardous type of carrier based on polymers modified to have Teflon-like properties. The team added fluorinated chains to a coating material known as polyethyleniamine to improve compatibility with the lipid-rich environment of cell membranes. Experiments in cell cultures demonstrated that with only a small amount of this new coating, RNA could be shuttled into tumors while preserving membrane structure. Subsequent trials in mice showed higher tumor inhibition rates than those seen with non-fluorinated polymer coatings. A low toxicity and high efficiency nucleic acid delivery system is the key to the successful implementation of gene therapy. In this study, a novel fluorinated polycationic carrier was used to effectively inhibit tumor growth by targeting VEGF genes with RNAi technology based on its unique fluorine effect, providing a feasible strategy for future clinical solid tumor treatment.